Haritha Reddy

476 total citations
19 papers, 342 citations indexed

About

Haritha Reddy is a scholar working on Oncology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Haritha Reddy has authored 19 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Haritha Reddy's work include Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Platelet Disorders and Treatments (3 papers). Haritha Reddy is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Platelet Disorders and Treatments (3 papers). Haritha Reddy collaborates with scholars based in United States, India and United Kingdom. Haritha Reddy's co-authors include Bryan J. Schneider, Andrew W. Tai, Michael J. Englesbe, Gregory P. Kalemkerian, Patricia F. Theurer, Richard L. Prager, Angel Qin, Gaetano Paone, Francis Shannon and Gail F. Bell and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Annals of Surgery.

In The Last Decade

Haritha Reddy

18 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haritha Reddy United States 8 116 115 99 74 71 19 342
Philip Joseph India 12 133 1.1× 145 1.3× 99 1.0× 88 1.2× 12 0.2× 29 389
Fabian J. Brunner Germany 12 180 1.6× 163 1.4× 40 0.4× 42 0.6× 10 0.1× 35 374
Omid Fatemi United States 8 212 1.8× 55 0.5× 107 1.1× 44 0.6× 26 0.4× 13 409
Ceyhan Türkkan Türkiye 11 355 3.1× 103 0.9× 179 1.8× 84 1.1× 36 0.5× 41 538
Andrew Woolston United Kingdom 10 178 1.5× 67 0.6× 135 1.4× 60 0.8× 16 0.2× 19 523
Paul J. Dluzniewski United States 11 108 0.9× 155 1.3× 68 0.7× 98 1.3× 25 0.4× 22 478
Nathan Better Australia 10 179 1.5× 113 1.0× 75 0.8× 66 0.9× 11 0.2× 39 375
Hannelore Haubelt Germany 14 200 1.7× 101 0.9× 25 0.3× 84 1.1× 55 0.8× 22 747
Mike Gorenchtein United States 5 63 0.5× 78 0.7× 54 0.5× 45 0.6× 28 0.4× 11 427
Marta Fuentes Spain 10 166 1.4× 97 0.8× 72 0.7× 169 2.3× 74 1.0× 46 431

Countries citing papers authored by Haritha Reddy

Since Specialization
Citations

This map shows the geographic impact of Haritha Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haritha Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haritha Reddy more than expected).

Fields of papers citing papers by Haritha Reddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haritha Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haritha Reddy. The network helps show where Haritha Reddy may publish in the future.

Co-authorship network of co-authors of Haritha Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of Haritha Reddy. A scholar is included among the top collaborators of Haritha Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haritha Reddy. Haritha Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Patil, Chandrashekar M, et al.. (2024). A Case Report of Whitmore's Disease: A True Masquerader. Cureus. 16(1). e52409–e52409. 1 indexed citations
3.
Kostyak, John C., et al.. (2022). Phosphorylation on Syk Y342 is important for both ITAM and hemITAM signaling in platelets. Journal of Biological Chemistry. 298(8). 102189–102189. 12 indexed citations
4.
Kumar, Pramod, et al.. (2022). Co-occurrence of linear scleroderma en coup de sabre and segmental vitiligo on the face. BMJ Case Reports. 15(5). e250056–e250056. 1 indexed citations
5.
Kostyak, John C., et al.. (2021). Phosphorylation of protein kinase Cδ Tyr311 positively regulates thromboxane generation in platelets. Journal of Biological Chemistry. 296. 100720–100720. 3 indexed citations
6.
Reddy, Haritha, Angel Qin, & Gregory P. Kalemkerian. (2020). Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors. Expert Opinion on Emerging Drugs. 25(3). 353–366. 4 indexed citations
7.
Reddy, Haritha, Elizabeth J. Maynes, Thomas J. O’Malley, et al.. (2020). Utilization of extracorporeal life support for diffuse alveolar damage and diffuse alveolar hemorrhage: A systematic review. Artificial Organs. 45(6). 559–568. 3 indexed citations
8.
Qin, Angel, Haritha Reddy, Frank Weinberg, & Gregory P. Kalemkerian. (2020). Cyclin-dependent kinase inhibitors for the treatment of lung cancer. Expert Opinion on Pharmacotherapy. 21(8). 941–952. 26 indexed citations
9.
Reddy, Haritha, et al.. (2019). P2.04-35 Immune Related Adverse Events in NSCLC Patients Treated with Immune Checkpoint Therapy Who Received the Influenza Vaccination vs No Vaccination. Journal of Thoracic Oncology. 14(10). S722–S722. 1 indexed citations
10.
Reddy, Haritha, Jae Hwan Choi, Elizabeth J. Maynes, et al.. (2019). Concomitant vs staged orthotopic liver transplant after cardiac surgical procedures. Transplantation Reviews. 33(4). 231–236. 5 indexed citations
11.
Reddy, Haritha, et al.. (2019). The protein tyrosine phosphatase PTPN7 is a negative regulator of ERK activation and thromboxane generation in platelets. Journal of Biological Chemistry. 294(33). 12547–12554. 15 indexed citations
12.
Choi, Jae Hwan, Jessica G.Y. Luc, Matthew P. Weber, et al.. (2019). Heparin-induced thrombocytopenia during extracorporeal life support: incidence, management and outcomes. Annals of Cardiothoracic Surgery. 8(1). 19–31. 40 indexed citations
13.
Hough, Shannon, et al.. (2019). Real-world comparison of immune checkpoint inhibitors in non-small cell lung cancer following platinum-based chemotherapy. Journal of Oncology Pharmacy Practice. 26(3). 564–571. 17 indexed citations
14.
Reddy, Haritha, et al.. (2019). Immune related adverse events in NSCLC patients treated with immune checkpoint therapy who received the influenza vaccination versus no vaccination.. Journal of Clinical Oncology. 37(15_suppl). e20657–e20657. 2 indexed citations
15.
Reddy, Haritha, Bryan J. Schneider, & Andrew W. Tai. (2018). Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis. Clinical and Translational Gastroenterology. 9(9). e180–e180. 72 indexed citations
16.
Reddy, Haritha, Alison Duffy, Noa G. Holtzman, & Ashkan Emadi. (2016). The role of β-elimination for the clinical activity of hypomethylating agents and cyclophosphamide analogues.. PubMed. 3(1). 1–8. 3 indexed citations
17.
Reddy, Haritha, Terry Shih, Michael J. Englesbe, et al.. (2013). Analyzing “Failure to Rescue”: Is This an Opportunity for Outcome Improvement in Cardiac Surgery?. The Annals of Thoracic Surgery. 95(6). 1976–1981. 71 indexed citations
18.
Smith, Margaret E., Adnan Hussain, Haritha Reddy, et al.. (2013). The Importance of Improving the Quality of Emergency Surgery for a Regional Quality Collaborative. Annals of Surgery. 257(4). 596–602. 65 indexed citations
19.
Smith, Margaret E., Adnan Hussain, Kola Olugbade, et al.. (2012). Exploring Variation in Emergent Surgical Outcomes in the Michigan Surgical Quality Collaborative: A Fertile Area for Quality Improvement. Journal of Surgical Research. 172(2). 212–213. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026